Bayer Aktiengesellschaft Stock Book Value Per Share
| BAYA Stock | EUR 4.80 0.14 2.83% |
Bayer Aktiengesellschaft fundamentals help investors to digest information that contributes to Bayer Aktiengesellscha's financial success or failures. It also enables traders to predict the movement of Bayer Stock. The fundamental analysis module provides a way to measure Bayer Aktiengesellscha's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bayer Aktiengesellscha stock.
Bayer |
Bayer Aktiengesellschaft Company Book Value Per Share Analysis
Bayer Aktiengesellscha's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Bayer Aktiengesellscha Book Value Per Share | 10.50 X |
Most of Bayer Aktiengesellscha's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of Bayer Aktiengesellschaft is about 10.5028 times. This is 717.81% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The book value per share for all Germany stocks is 99.46% higher than that of the company.
Bayer Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayer Aktiengesellscha's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bayer Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Bayer Aktiengesellscha by comparing valuation metrics of similar companies.Bayer Aktiengesellscha is currently under evaluation in book value per share category among its peers.
Bayer Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Current Valuation | 82.93 B | |||
| Shares Outstanding | 3.93 B | |||
| Shares Owned By Institutions | 0.10 % | |||
| Price To Earning | 12.22 X | |||
| Price To Book | 1.32 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 44.08 B | |||
| Gross Profit | 30.87 B | |||
| EBITDA | 6.45 B | |||
| Net Income | 1000 M | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 2.09 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.13 % | |||
| Current Ratio | 1.23 X | |||
| Book Value Per Share | 10.50 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 1.17 X | |||
| Price To Earnings To Growth | 1.28 X | |||
| Target Price | 15.3 | |||
| Number Of Employees | 102.3 K | |||
| Beta | 1.17 | |||
| Market Capitalization | 55.35 B | |||
| Total Asset | 120.24 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 4.07 % | |||
| Net Asset | 120.24 B |
About Bayer Aktiengesellscha Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayer Aktiengesellschaft's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayer Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayer Aktiengesellschaft based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Stock
Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.